Artwork

Content provided by Pradyumna Prasad. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pradyumna Prasad or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep. 50: mRNA vaccines in India ft. Soham Sankaran

1:01:43
 
Share
 

Manage episode 374831844 series 2981859
Content provided by Pradyumna Prasad. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pradyumna Prasad or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

I spoke to Soham Sankaran who runs PopVax, an Indian mRNA vaccine company. Their goal is to build low-cost broadly-protective vaccines to protect against the entire sarbecovirus species. Read Soham's experience here (https://chronicles.popvax.com/p/three-meetings-and-six-million-funerals) as a complement to this episode. Also check out their jobs page (https://jobs.popvax.com/) for opportunities.

This episode includes

  • How he started PopVax and (went bankrupt in the process)
  • Why there hasn't been a successful Indian mRNA vaccine yet
  • Why developing countries can't afford drugs for rare diseases
  • What they're doing to fix it
  • Their biggest constraints
--- Send in a voice message: https://podcasters.spotify.com/pod/show/pradyumna-sp/message
  continue reading

57 episodes

Artwork
iconShare
 
Manage episode 374831844 series 2981859
Content provided by Pradyumna Prasad. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pradyumna Prasad or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

I spoke to Soham Sankaran who runs PopVax, an Indian mRNA vaccine company. Their goal is to build low-cost broadly-protective vaccines to protect against the entire sarbecovirus species. Read Soham's experience here (https://chronicles.popvax.com/p/three-meetings-and-six-million-funerals) as a complement to this episode. Also check out their jobs page (https://jobs.popvax.com/) for opportunities.

This episode includes

  • How he started PopVax and (went bankrupt in the process)
  • Why there hasn't been a successful Indian mRNA vaccine yet
  • Why developing countries can't afford drugs for rare diseases
  • What they're doing to fix it
  • Their biggest constraints
--- Send in a voice message: https://podcasters.spotify.com/pod/show/pradyumna-sp/message
  continue reading

57 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide